Basics Exagen Inc. IPO Date: September 20, 2019 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $148.83M Activated in VL: True Average Daily Range Avg Daily Range: $0.33 | 3.85% Avg Daily Range (30 D): $0.26 | 4.39% Avg Daily Range (90 D): $0.20 | 4.36% Institutional Daily Volume Avg Daily Volume: .04M Avg Daily Volume (30 D): .25M Avg Daily Volume (90 D): .15M Trade Size Avg Trade Size (Sh.): 117 Avg Trade Size (Sh.) (30 D): 145 Avg Trade Size (Sh.) (90 D): 146 Institutional Trades Total Inst.Trades: 54 Avg Inst. Trade: $1.59M Avg Inst. Trade (30 D): $.58M Avg Inst. Trade (90 D): $.58M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.99M Avg Closing Trade (30 D): $.58M Avg Closing Trade (90 D): $.58M Avg Closing Volume: 164.8K         News Jun 13, 2024 @ 12:50 PM Why Fast-paced Mover Exagen (XGN) Is a Great Choic... Source: Zacks Equity Research Jun 10, 2024 @ 12:03 PM Time to Play 5 Top-Ranked Stocks With Rising P/E? Source: Sanghamitra Saha May 13, 2024 @ 1:10 PM Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Es... Source: Zacks Equity Research May 7, 2024 @ 9:10 PM Quanterix Corporation (QTRX) Reports Q1 Loss, Tops... Source: Zacks Equity Research Apr 30, 2024 @ 8:05 PM Exagen to Announce First Quarter 2024 Results on M... Source: Exagen Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.84 $-.2 $-.2 Diluted EPS $-.84 $-.2 $-.2 Revenue $ 56.72M $ 15.5M $ 13.66M Gross Profit $ 33.64M $ 9.12M $ 8.48M Net Income / Loss $ -15.51M $ -3.75M $ -3.76M Operating Income / Loss $ -14M $ -3.37M $ -3.38M Cost of Revenue $ 23.09M $ 6.38M $ 5.18M Net Cash Flow $ -16.07M $ -10.84M $ M PE Ratio